Publications
5674 Results
- Journal / Conference
- Journal of Thoracic Oncology 1(9):996-1001
- Year
- 2006
- Research Committee(s)
- Lung
- Study Number(s)
- S0327
Bortezomib (PS-341) in relapsed or refractory extensive stage small cell lung cancer: a Southwest Oncology Group Phase II Trial (S0327)
- Journal / Conference
- Cancer 106(2):320-328
- Year
- 2006
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase
- Journal / Conference
- Journal of Thoracic Oncology 1(9):991-995
- Year
- 2006
- Research Committee(s)
- Lung
- Study Number(s)
- S9914
Phase II trial of paclitaxel, carboplatin and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914
- Journal / Conference
- Journal of Clinical Oncology 24(24):3984-3990
- Year
- 2006
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9346
Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group trial 9346 (INT-0162)
- Journal / Conference
- Proc of the ASCO, Journal of Clinical Oncology 24(18S):#510
- Year
- 2006
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-9410 (INT-0148) (CALGB-9344)
HER2 predicts benefit from adjuvant paclitaxel after AC in node-positive breast cancer: CALGB 9344.
- Journal / Conference
- Journal of Clinical Oncology 24(19):3121-3127
- Year
- 2006
- Research Committee(s)
- Lymphoma
- Study Number(s)
- E4494
Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
- Journal / Conference
- Blood 107(11):4207-4213
- Year
- 2006
- Research Committee(s)
- Lymphoma
- Study Number(s)
- E4494
Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study
- Journal / Conference
- Blood 107(3):1101-1107
- Year
- 2006
- Research Committee(s)
- Lymphoma
- PMID
- PMID16239429
- PMC
- PMC1895908
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions
- Journal / Conference
- Proc of the National Academy of Sciences 103(7):2352-2357
- Year
- 2006
- Research Committee(s)
- Lymphoma
- PMID
- PMID16461462
- PMC
- PMC1413716
Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma
- Journal / Conference
- Blood 108(1):311-318
- Year
- 2006
- Research Committee(s)
- Lymphoma